Carrie Bourdow

Track

Insider profile

Currently holds positions in Carisma Therapeutics Inc, Nabriva Therapeutics PLC and Trevena Inc

Performance

Overall performance
1.5
Performance over holding periods
1.5
30 days 90 days 120 days
Average return -18% 8.2% 15.1%
Success rate 2% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Carisma Therapeutics Inc Feb. 20, 2020 -
Independent Member of the Supervisory Board Nabriva Therapeutics PLC June 23, 2017 -
President, Chief Executive Officer, Director Trevena Inc Oct. 1, 2018 -
Chief Operating Officer, Executive Vice President Trevena Inc Feb. 2, 2018 - Oct. 1, 2018
Senior Vice President, Chief Commercial Officer Trevena Inc May 4, 2015 - Feb. 2, 2018
Carrie Bourdow's trades of Nabriva Therapeutics PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
220.42
Quantity 97,544 -43.9%
Value US$1,088,500
US Trevena Inc (TRVN)
Transaction date
Purchase
Price
226.96
Quantity 40,610 +42.0%
Value US$4,657,848
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-08-03 2022-08-01
S Sale
97,544 -43.9%
220.42
US$1,088,500 		97,544 -43.9% 220.42 US$1,088,500
2021-08-04 2021-08-02
S Sale
13,393 +42.8%
254.62
US$3,895,544 		13,393 +42.8% 254.62 US$3,895,544
2021-06-28 2021-06-28
US Trevena Inc (TRVN)
B Purchase
40,610 +42.0%
226.96
US$4,657,848 		40,610 +42.0% 226.96 US$4,657,848